Medindia LOGIN REGISTER
Medindia
Advertisement

High Potency Active Pharmaceutical Ingredients (HPAPI) Global Market - Forecast To 2023

Thursday, November 9, 2017 Drug News
Advertisement
The drugs are classified as High Potent if its Occupational Exposure Limit (OELs) ? 10µg/m3.

LONDON, Nov. 8, 2017 /PRNewswire/ -- Download the full report: https://www.reportbuyer.com/product/5184639The HPAPI global market is progressively increasing in terms of revenue and the rise in demand for outsourcing these intermediates, manufacturing is driven by expansion of oncology sector, which is the fastest among overall pharmaceutical sector.The global HPAPI market is valued to be $XX million in 2016 and poised to grow at a CAGR of X% to reach $27,293.4 million by 2023. HPAPI market is mainly classified by customer base, by business type, by molecule type and Applications. The global HPAPI market is broadly classified as Innovative HPAPI and Generic HPAPI based on customer base. Based on business type, the market is classified into Captive HPAPI & Merchant HPAPI. HPAPI market is segmented on the basis of molecule type as Synthetic HPAPI and Biotech HPAPI. HPAPI market application segment is classified into Oncology, Cardiovascular, Central Nervous System, Hormonal, Glaucoma, Infectious, metabolic, Inflammation and other therapeutic applications.Among Innovative & generic HPAPI, Innovative HPAPI occupies the major share in 2016 and generic HPAPIs expected to grow at a highest CAGR from 2016 to 2023. Among business type, Captive HPAPI occupies the major share of XX% in 2016 and Merchant HPAPI is expected to grow at a highest CAGR of X% from 2016 to 2023 to reach $XX million by 2023. Among molecule type, Synthetic HPAPI occupies the major share in 2016 and is expected to grow at a CAGR of X% from 2016 to 2023 to reach $XX million by 2023. Among Application segment, Oncology commanded the larger revenue of $XX million in 2016 and is expected to grow at a highest CAGR of X% from 2016 to 2023.Increasing incidence of chronic and age related diseases, rapid growth in oncology market, growing demand for Antibody Drug Conjugates (ADC), technological advancements in HPAPI market, growing CMOs are some of the factors which are driving the market. Requirement of large investments, stringent safety and handling specifications associated with production of HPAPI, stringent regulations are the factors hindering the market.North America accounts for the highest market share in 2016 and followed by Europe. However, Asian countries especially China and India are the fastest growing regions with its growing demand for HPAPIs. Asia-Pacific is projected to grow with a highest CAGR of XX% from 2016 to 2023.Major players in HPAPI market include Alkermes plc (Ireland),Cambrex Corporation (U.S.),Dishman group (India), Dr. Reddy's Laboratories (India), Lonza Group (Switzerland), Novasep (U.S.), Patheon N.V.( Netherland)(ThermoFisher Scientific), Pfizer (U.S.), Merck KGaA (Germany) and Teva Pharmaceutical Industries (Israel).The report provides an in depth market analysis of the above mentioned segments across the following regions:North AmericaEuropeAsia-Pacific• Rest of the WorldDownload the full report: https://www.reportbuyer.com/product/5184639 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers https://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com

View original content:http://www.prnewswire.com/news-releases/high-potency-active-pharmaceutical-ingredients-hpapi-global-market--forecast-to-2023-300552221.html

SOURCE ReportBuyer

Sponsored Post and Backlink Submission


Latest Press Release on Drug News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close